StockDrifts LogoStockDrifts

Exor N.V. 13F Portfolio

Portfolio Manager
Exor N.V.
Performance
+5.09% (2026 Q2)
AUM (13F)
$5.46B
# of Holdings
3
Performance Rank
Allocation (Top 20)
7.35%
Latest filing
Q2 2026

Exor N.V. Holdings Map

Top 2 Exor N.V. Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
VIA
VIA TRANSN INC
4.69%14.12M$256.2M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 14.12M shares2025-Q4: 14.12M shares2026-Q1: 14.12M shares2026-Q2: 14.12M shares
$48.08(-51.37%)
2026-06-30
CLVT
CLARIVATE PLC
2.66%67.29M$145.4M
+0.00%(+0)
2025-Q2: 67.29M shares2025-Q3: 67.29M shares2025-Q4: 67.29M shares2026-Q1: 67.29M shares2026-Q2: 67.29M shares
$8.42(-75.65%)
2026-06-30

About Exor N.V.’s portfolio

Exor N.V. reports $5.46B in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are VIA (4.7%) and CLVT (2.7%). The top 20 holdings account for 7.35% of reported assets. Its disclosed equity book has returned -82.77% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
VIA — 63.8% ($256.16M)CLVT — 36.2% ($145.36M)
100%in top 2
  • VIA63.8%
  • CLVT36.2%

Unlock alerts, watchlists & AI chat

Sign up free to track Exor N.V., compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Exor N.V.’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1589122). View Exor N.V.’s 13F filings on SEC

More 13F analyses

View all